SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-039795
Filing Date
2023-05-15
Accepted
2023-05-15 16:16:36
Documents
14
Period of Report
2023-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea178552-8k_gamida.htm   iXBRL 8-K 27733
2 PRESS RELEASE, DATED MAY 15, 2023 ea178552ex99-1_gamida.htm EX-99.1 92740
6 GRAPHIC ex99-1_001.jpg GRAPHIC 2482
  Complete submission text file 0001213900-23-039795.txt   309454

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE gmda-20230515.xsd EX-101.SCH 2968
4 XBRL LABEL FILE gmda-20230515_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE gmda-20230515_pre.xml EX-101.PRE 22365
8 EXTRACTED XBRL INSTANCE DOCUMENT ea178552-8k_gamida_htm.xml XML 3614
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38716 | Film No.: 23922638
SIC: 2836 Biological Products, (No Diagnostic Substances)